NCT02567539View on ClinicalTrials.gov

Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

May 27, 2015

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Recurrent High Grade Glioma
Interventions
RADIATION

IMRT with or without radiosensitive therapy

Re-irradiation with hypofractionated intensity modulated radiation therapy (IMRT), using VMAT RapidArc

DRUG

Radiosensitive therapy

Radiosensitive therapy with Temozolomide

Trial Locations (1)

20089

Istituto Clinico Humanitas, Rozzano

All Listed Sponsors
lead

Istituto Clinico Humanitas

OTHER

NCT02567539 - Hypofractionated Stereotactic Radiotherapy for Patients With Recurrent High Grade Glioma | Biotech Hunter | Biotech Hunter